WAYNE, Pa., Oct. 28, 2020 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) today announced the expansion of its UroLift® System portfolio with the introduction of the UroLift® Advanced Tissue ...
Both Rezūm® and Urolift® are relatively new treatments for BPH, as countries begin reimbursing for these treatments, the market will grow significantly.” — Dr. Kamran Zamanian, Senior Partner and CEO ...
PLEASANTON, Calif.--(BUSINESS WIRE)--NeoTract, Inc., a medical device company focused on addressing unmet needs in the field of urology, today announced that First Coast Service Options, Inc., the ...
WAYNE, Pa., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has announced it is combining its leading industry clinical ...
Teleflex Inc. received favorable results for a multi-center study reaffirming the safety and effectiveness of its UroLift System. The Wayne, PA-based company said the results were published in the ...
(Reuters) - Medical device maker Teleflex Inc said on Tuesday it would buy privately held NeoTract Inc in its second billion-dollar deal in the past nine months, to strengthen its portfolio of urology ...
NeoTract has presented 5-year data from a clinical trial of its UroLift device. The data link the device to sustained effects on lower urinary tract symptoms, including improved peak urinary flow rate ...
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX) today announced that 100,000 patients have been treated globally with its minimally invasive UroLift ® System, a safe and effective ...
A Bay Area company believes it has a solution for an uncomfortable problem that affects an estimated 37 million men in the U.S. alone. PLEASANTON, Calif. (KGO) -- A Bay Area company believes it has a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results